Peak Bio
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3350 W Bayshore Rd Ste 100, Palo Alto, C...Phone Number
(650) 549-9103Website
www.peak-bio.comRevenue
<$5 MillionStock Symbol
PKBOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Peak Bio
Peak Bio is a clinical-stage biopharmaceutical company focused on commercializing innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare and specialty diseases and cancer. They are headquartered in Palo Alto, California.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Peak Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Peak Bio launches new products
Earning: See what the market has to say on Peak Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Peak Bio
Check out if Peak Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Peak Bio has new funding data
Click to see if Peak Bio had a recent Job posting/layoffs
Check if Peak Bio has recently received funding, and reach out quickly before it becomes old news!
Peak Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Peak Bio
Compare insights from companies similar to Peak Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Peak Bio
<$5M
11-50
Public
-
2015
N/A
Company Profile Activity
Activity Insights
Peak Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Peak Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Peak Bio.
Peak Bio Tech Stack
A closer look at the technologies used by Peak Bio
See more technologies
Most Recent Scoops
Earnings
Financial Planning, Financial Systems, Financial Reporting, Financial Operations, Financial Strategy, Financial Transactions, Financing & Debt, Operations
Earnings
Earnings
Earnings
Earnings
Financing & Debt
Peak Bio News & Media
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
BOSTON and LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with the merger of Akari Therapeutics, Plc (the Company) and Peak Bio, Inc. At a General Meeting held in relation to the merger at 9:00 a.m. Eastern Time on Thursday, November 7, 2024 at the Company’s offices in London, shareholders approved the Company’Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
BOSTON and LONDON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces the effectiveness of the Form S-4, originally filed with the SEC on September 13, 2024 related to the merger of Akari Therapeutics, Plc (the Company) and Peak Bio, Inc. The Form S-4 was declared effective by the SEC on October 11, 2024 allowing the Company to definitively scheduleRob Bazemore Appointed to the Board of Directors of Akari Therapeutics
BOSTON and LONDON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces the appointment of Rob Bazemore, experienced life sciences leader, to the Akari Board of Directors effective September 17, 2024.Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Peak Bio
Sign Up For FreeTo access detailed company insights
Peak Bio is a clinical-stage biopharmaceutical company focused on commercializing innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare and specialty diseases and cancer. They are headquartered in Palo Alto, California.... Read More
